SCHEMBL735054

SCHEMBL735054

CN(C)C1(c2ccccc2)CC=C(c2[nH]c3ccccc3c2CCN2CCc3ccccc3C2)CC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
HTR2A P28223 4/20 0.42
DRD2 P14416 3/20 0.42
HTR1A P08908 2/20 0.42
HTR7 P34969 2/20 0.42
HRH1 P35367 2/20 0.42
DRD3 P35462 2/20 0.42
SLC6A4 P31645 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRL1 P41146 1/20 0.41
HTR2C P28335 2/20 0.41
SIGMAR1 Q99720 6/20 0.40
KCNH2 Q12809 2/20 0.39
HDAC1 Q13547 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL735786 0.94 OPRM1 (0.42) KDM4EGAAMAPTHTTKMT2A
SCHEMBL735511 0.89 HTR2A (0.46) HTR2ADRD2OPRM1OPRL1HTR2C
SCHEMBL733107 0.88 HTR2A (0.55) HTR2ADRD2OPRM1OPRL1HTR2C
SCHEMBL735588 0.87 HTR2A (0.55) HTR2ADRD2OPRM1OPRL1HTR2C
SCHEMBL734860 0.85 HTR2A (0.44) HTR2ADRD2OPRM1OPRL1HTR2C
SCHEMBL735977 0.84 OPRM1 (0.41) HTR2ADRD2OPRM1OPRL1HTR2C
SCHEMBL736020 0.83 OPRM1 (0.41) KDM4EMAPTKMT2AHTR2ADRD2
SCHEMBL735512 0.82 OPRM1 (0.44) HTR2ADRD2OPRM1OPRL1HTR2C
SCHEMBL734730 0.81 OPRM1 (0.42) KDM4EHTR2ADRD2OPRM1OPRL1
SCHEMBL735785 0.81 OPRM1 (0.42) HTR2ADRD2OPRM1OPRL1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 KDM4E 2643/4885GAA 534/4885MAPT 3593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.